Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/1999
08/24/1999US5942511 Allylthiopyridazine derivatives and process for preparing the same
08/24/1999US5942419 RsbW-1 encoding nucleic acids
08/24/1999US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation
08/24/1999US5942234 Hepatitis C virus asialoglycoproteins
08/24/1999CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors
08/20/1999CA2249653A1 Novel compounds
08/19/1999WO1999041375A2 Human receptor proteins
08/19/1999WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG
08/19/1999WO1999041282A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999WO1999041252A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041251A1 Antagonists of gonadotropin releasing hormone
08/19/1999WO1999041246A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999WO1999041240A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
08/19/1999WO1999041224A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999WO1999040928A1 Novel mixed amylin activity compounds
08/19/1999WO1999040923A1 Preventive and therapeutic agent for fatty liver
08/19/1999WO1999040916A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
08/19/1999WO1999040914A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999WO1999040910A1 Anti-inflammatory agents
08/19/1999WO1999040906A2 Method and composition for treatment of inflammatory conditions
08/19/1999WO1999040870A1 Light-activated tooth whitening composition and method of using same
08/19/1999WO1999029662A3 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
08/19/1999WO1999023996A3 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor
08/19/1999WO1999015210B1 Bioadhesive compositions and methods for topical administration of active agents
08/19/1999WO1999001416A3 1-amino-alkylcyclohexane nmda receptor antagonists
08/19/1999WO1998052514A3 Treatment of hepatic cirrhosis
08/19/1999DE19806348A1 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln 3,4-dihydroquinoline derivatives and their use in medicaments
08/19/1999CA2750101A1 Light-activated tooth whitening composition and method of using same
08/19/1999CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
08/19/1999CA2320515A1 Therapeutic uses of keratinocyte growth factor-2
08/19/1999CA2320427A1 Human receptor proteins
08/19/1999CA2320285A1 Anti-inflammatory agents
08/19/1999CA2319173A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
08/19/1999CA2319082A1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
08/19/1999CA2318966A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
08/19/1999CA2318957A1 Antagonists of gonadotropin releasing hormone
08/19/1999CA2317451A1 Antagonists of gonadotropin releasing hormone
08/18/1999EP0935601A2 Arylamino fused pyridines and pyrimidines
08/18/1999EP0935465A1 Novel substituted imidazole compounds
08/18/1999EP0935458A1 Compositions containing at least one nucleic acid
08/18/1999EP0935417A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
08/18/1999EP0804152B1 Lactulose lozenges
08/18/1999EP0796257B1 Malonic acid based matrix metalloproteinase inhibitors
08/18/1999CN1226236A New compounds
08/18/1999CN1225830A Jaundice diminishing medicine good for liver
08/17/1999US5939583 Antiarthritic agents; bone, cardiovascular, brain, nervous system disorders; antitumor and antimetastasis agents
08/17/1999US5939525 Methods of treating inflammation and compositions therefor
08/17/1999US5939449 Novel compounds having high affinity for the neurotensin receptors
08/17/1999US5939434 Tetrazolyl-substituted quinuclidines as substance P antagonists
08/17/1999US5939433 Quinuclidine derivatives
08/17/1999US5939432 Thiophenes useful for modulating the adenosine receptor
08/17/1999US5939426 Also for motion sickness and vertigo
08/17/1999US5939413 Tachykinin mediated diseases in humans for respiratory system disorders like asthma, bronchitis, rhinitis or eye diseases or skin disorders
08/17/1999US5939411 Piperidine derivatives substituted at position 4 with new functions other than those described previously have a high affinity for neurokinin receptors and are useful for treatment of substance p and neurokinin dependent pathologies
08/17/1999US5939405 Potassium channel modulators
08/17/1999US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents
08/17/1999US5939073 Fish pancreatic disease virus
08/17/1999US5939052 Oral formulations contained in physically separated compartments of a dentifrice dispenser
08/17/1999US5939050 Antimicrobial compositions
08/17/1999CA2179008C 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
08/12/1999WO1999040091A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040073A2 Tryptase inhibitors
08/12/1999WO1999039699A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
08/12/1999WO1999039686A1 Composition for the treatment of halitosis
08/12/1999WO1999006032A3 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/11/1999EP0934954A1 Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934934A2 Methods of preparing substituted 3-phenyl- and 3-pyridyl-4(3H)-quinazolinones and atropisomers thereof
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934292A1 Metalloproteinase inhibitors
08/11/1999EP0934291A1 Protease inhibitors
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934282A1 1,4-benzodiazepinones and their uses as cck antagonists
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934267A1 $g(a)-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
08/11/1999EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/11/1999EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934074A1 Use of ginkgo biloba flavonoidic extract substantially devoid or terpenes for oral hygiene and composition containing such extract
08/11/1999EP0934071A1 Non-aqueous colonic purgative formulations
08/11/1999EP0934067A1 Antimicrobial compositions
08/11/1999EP0934058A2 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
08/11/1999EP0933997A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors
08/11/1999EP0781282B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
08/11/1999EP0756605B1 Peptides as therapeutic agents for the treatment of auto-immune diseases
08/11/1999EP0725651B1 Hemoregulatory peptides
08/11/1999EP0678097B1 Novel colon- or ileum-specific steroid derivatives
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225631A Bioconjugates of manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysis for dismutating superoxide
08/11/1999CN1225624A Inhibition of matrix metalloproteases by substituted phenethyl compounds
08/11/1999CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds
08/11/1999CN1225622A Substituted oxobutyric acids as matrix metalloprotease inhibitor
1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 1258